0      0

AONN+ Annual 2021 Virtual Conference

SAT13 - Industry Sponsored Session |A Treatment Option for Patients With Myelodysplastic Syndromes Presented by Bristol Myers Squibb

Nov 20, 2021 4:00pm ‐ Nov 20, 2021 5:00pm


This program will share information about a treatment option for myelodysplastic syndromes including an overview of MDS, ineffective erythropoiesis, the pivotal phase 3 trial design, efficacy, safety, dosing, and administration.


You must be logged in and own this session in order to post comments.